Genomics of unrelated-donor hematopoietic cell transplantation

Effie Petersdorf, Claudio Anasetti, Paul J. Martin, Ann Woolfrey, Anajane Smith, Eric Mickelson, Mari Malkki, Ming Tseh Lin, John A. Hansen

Research output: Contribution to journalReview articlepeer-review

Abstract

Unrelated-donor hematopoietic cell transplantation is a proven curative modality for hematologic malignancies. The success of unrelated-donor transplantation has been achieved through a better understanding of the immunobiology of the HLA system and through more precise and comprehensive matching of donors and recipients. The extensive polymorphism of HLA genes confers important biological implications affecting engraftment, graft-versus-host disease and overall survival. Although more-complete HLA identity of the donor and recipient is associated with optimal transplant outcome, new information suggests that not every HLA disparity is functionally relevant. Future advances in unrelated-donor transplantation must include the identification of tolerable HLA mismatches, so that more patients may benefit from this therapeutic modality. Furthermore, the role of cytokine-gene polymorphisms and minor histocompatibility genes in transplant outcome requires investigation. Delineation of the function of these markers as transplantation determinants may provide alternative means for optimizing the results of hematopoietic cell transplantation.

Original languageEnglish (US)
Pages (from-to)582-589
Number of pages8
JournalCurrent Opinion in Immunology
Volume13
Issue number5
DOIs
StatePublished - Oct 1 2001
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Genomics of unrelated-donor hematopoietic cell transplantation'. Together they form a unique fingerprint.

Cite this